NEW YORK, Aug. 1, 2023 /PRNewswire/ — Hospital for Special Surgery (HSS), has been ranked the No. 1 hospital in the nation for orthopedics for the 14th consecutive year, and advanced to No. 2 for rheumatology, in the U.S. News & World Report 2023-2024 Best Hospitals: Specialty Rankings©* analysis.
U.S. News evaluated more than 4,500 hospitals in 15 specialties. Hospital performance was assessed using a variety of measures, including outcomes, level of nursing care, patient experience, and available technology such as computer-assisted orthopedic surgery, according to U.S. News. The methodology factored in data from the Centers for Medicare & Medicaid Services, American Hospital Association, professional organizations, and medical specialists.
“This U.S. News analysis validates that we are providing the highest quality care in fields that are advancing steadily,” said HSS CEO Louis A. Shapiro. “We remain at the top by setting a higher standard for ourselves in every aspect of what we do, from patient care to quality to culture and beyond. Every single member of the HSS team plays a vital role.”
HSS is the world’s leading academic medical center specialized in musculoskeletal health, and the only hospital in North America designated by the World Economic Forum to serve in the Global Coalition for Value in Healthcare. HSS maintains the lowest readmission rates for orthopedics in the nation, and among the lowest rates for infections and complications.
“Our 160 years of focus on musculoskeletal conditions is a distinguishing feature of HSS, enabling us to provide highly specialized care that benefits our patients and leads to the most reliably superior outcomes,” said Bryan T. Kelly, MD, MBA, president, surgeon-in-chief and medical director of HSS. “The high rankings reflect our special expertise, our strong dedication to evidence-based medicine, our constant focus on safety, and our steadfast commitment to research and innovation to advance the field of musculoskeletal care.”
“Individuals with rheumatic diseases face many challenges and we are committed to providing the most advanced, personalized and compassionate care for each of our patients,” said S. Louis Bridges, Jr., MD, PhD, physician-in-chief and chief of the Division of Rheumatology at HSS. “We are proud to be recognized for excellence by U.S. News and will continue to work as a team to maintain the highest standards of care and improve our patients’ lives.”
In 2022, HSS clinicians provided specialized care to more than 200,000 patients for all types of orthopedic and rheumatologic conditions, such as pain or injury to the back, neck or joints, osteoarthritis, rheumatoid arthritis, lupus, scleroderma, and psoriatic arthritis. Over the course of the year HSS performed more than 38,000 orthopedic surgical procedures.
HSS is the Official Hospital and provides Team Physicians to more than 20 high performing sports teams and leagues including Major League Pickleball, the New York Giants, New York Knicks, Brooklyn Nets, New York Liberty, New York Mets, New York Red Bulls, New York Road Runners, National Basketball Players Association, US Youth Soccer, and UFC. It is designated a Medical Center of Excellence by Fédération Internationale de Football Association (FIFA).
* Copyright © 2023 U.S. News & World Report, L.P. Data reprinted with permission from U.S. News.
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a third consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnosis, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.
SOURCE Hospital for Special Surgery
Controle su presión arterial: 7 cambios para controlar su salud
(Family Features) Lo que usted come y bebe, así como su nivel de actividad y sus hábitos, afectan la salud de su corazón y cerebro y son esenciales para controlar la presión arterial, el colesterol y más. La presión arterial alta (lecturas consistentemente superiores a 130/80 mm Hg) es una de las principales causas y un factor de riesgo controlable de enfermedades cardíacas y ataques o derrames cerebrales, así como de otros problemas como insuficiencia renal, pérdida de visión y problemas sexuales.
De hecho, casi la mitad de todos los adultos estadounidenses tienen presión arterial alta (hipertensión), según los Centros para el Control y la Prevención de Enfermedades, pero es posible que muchos ni siquiera se den cuenta de que la tienen a menos que experimenten otras complicaciones. Es más, el origen étnico también puede influir en sus factores de riesgo.
Por ejemplo, según la American Heart Association (Asociación Americana del Corazón), los adultos hispanos tienen una de las prevalencias más altas de presión arterial mal controlada, que es uno de los principales factores de riesgo de enfermedad cardíaca. Debido a barreras sistémicas de larga data, como la falta histórica de acceso a la atención de la salud y alimentos nutritivos, la comunidad hispana y latina se ve afectada de manera desproporcionada por enfermedades cardíacas y problemas de salud relacionados.
Las mujeres negras en edad fértil tienen más del doble de probabilidades de tener presión arterial descontrolada que las blancas, según una investigación presentada en una edición especial Go Red for Women del “Journal of the American Heart Association”. Además, la inseguridad alimentaria o la falta de acceso a alimentos saludables adecuados, que es uno de los factores sociales que pueden afectar el riesgo de presión arterial alta, es mayor entre las mujeres hispanas y negras en comparación con las mujeres blancas.
Para ayudar a mantener la presión arterial por debajo de 120/80 mm Hg y controlar los factores de riesgo, la American Heart Association, con el apoyo nacional de Elevance Health Foundation, recomienda estos cambios en el estilo de vida.
Mantener un peso saludable. Si tiene sobrepeso o es obeso, tiene un mayor riesgo de sufrir presión arterial alta. Perder tan solo 10 libras (o entre el 3 y el 5 % de su peso corporal) puede brindar beneficios para la salud, incluida la reducción o prevención de la presión arterial alta. Hable con su proveedor de cuidados de salud sobre un enfoque saludable para perder peso, incluida la ingesta calórica y las actividades que pueden ayudar tanto a perder como a mantener el peso.
Comer más saludable. Comer frutas y verduras, como mangos, aguacates y arándanos, puede reducir la presión arterial con el tiempo. Otras opciones inteligentes incluyen nueces y semillas, cereales integrales, lácteos bajos en grasa, proteínas magras y pescado. El plan de alimentaciónEnfoques dietéticos para detener la hipertensión (Dietary Approaches to Stop Hypertension) o DASH, está orientado a reducir la presión arterial y ayuda a crear un estilo de alimentación saludable para el corazón.
Reducir el sodio. Los estadounidenses consumen hasta el 75 % de su sodio de alimentos procesados como sopas, salsa de tomate, condimentos y productos enlatados. Para reducir el consumo, lea las etiquetas cuando compre y elija versiones bajas en sodio de sus comidas favoritas, omita la sal de mesa y considere especias y hierbas como alternativas de condimento.
Controlar el estrés. Se sabe que el estrés contribuye a los factores de riesgo de presión arterial alta, como la mala alimentación y el consumo excesivo de alcohol. Practicar técnicas de relajación, como el yoga o la respiración profunda, practicar la gratitud y hacer cosas que disfrute, pueden ayudar a reducir el estrés.
Estar activo. La actividad física no solo ayuda a controlar la presión arterial alta, sino que también ayuda a controlar el peso, fortalece el corazón y reduce los niveles de estrés. La American Heart Association recomienda al menos 150 minutos por semana de actividad física de intensidad moderada, como caminar a paso ligero.
Limitar el alcohol. Beber demasiado alcohol puede aumentar la presión arterial. Si bebe, limite su consumo a no más de dos tragos por día para los hombres y un trago por día para las mujeres.
Dejar de fumar. Cada vez que fuma, provoca un aumento temporal de la presión arterial. Tanto fumar como exponerse al humo del tabaco ajeno también aumentan el riesgo de acumulación de placa dentro de las arterias, un proceso que se sabe que acelera la hipertensión.
Encuentre más consejos para controlar su presión arterial en Heart.org/highbloodpressure.
Fotos cortesía de Getty Images
American Heart Association
Al B. Sure! & Rev. Al Sharpton: Championing Health Equity in Transplantation
Al B. Sure! and Rev. Al Sharpton unite to oppose Medicare cutbacks, advocating for health equity in transplantation to benefit minority communities.
In a powerful display of solidarity and determination, music legend Al B. Sure! and global civil rights leader Rev. Al Sharpton have come together to announce the formation of the “Health Equity in Transplantation Coalition.” This coalition aims to oppose the recent Medicare cutbacks for transplant patient blood tests that detect early signs of organ rejection, particularly affecting minority and underserved communities. With their shared commitment to justice and equality, Al B! will serve as the Executive Chairman, while Rev. Sharpton will play a vital role as the Senior Advisor.
The Impact of Medicare Coverage Restrictions:
On March 2, 2023, a private contractor known as a “Medicare Administrative Contractor” (MAC) announced restrictions on Medicare coverage for transplant patient blood tests. These tests, essential for detecting early signs of organ rejection, have been instrumental in safeguarding the health of transplant patients since 2017. However, the sudden change linking coverage to invasive surgical biopsies has caused confusion, delays, and cancellations, primarily affecting Black, Hispanic, Latino, and underserved transplant communities.
The Voice of Al B!:
As a successful organ transplant recipient and advocate for the transplant patient community, Al B! understands the importance of these blood tests firsthand. Having received a life-saving liver transplant in 2022, he emphasizes the need for accessible and non-invasive blood tests that can be conducted at home. Al B! believes that tying Medicare coverage to invasive biopsies places an undue burden on underserved transplant recipients, necessitating expensive travel, time off work for patients and caregivers, and hospital procedures.
The Support of Rev. Al Sharpton and Newt Gingrich:
Rev. Al Sharpton, renowned for his tireless work in defending the rights of minority communities, welcomes the support of former Republican Speaker Newt Gingrich in restoring Medicare coverage for surveillance blood tests. Their alignment, along with a broad bipartisan group of transplant patients, physicians, and members of Congress, highlights the urgent need to reverse these detrimental rollbacks. Rev. Sharpton emphasizes that these non-invasive tests provided a lifeline to Black, Hispanic, Latino, and underserved communities, and it is essential to expand access to better tools, not restrict them.
Addressing Disparities in Transplant Care:
Transplant care plays a critical role in the lives of Black, Hispanic, and Latino Americans, who account for 40% of transplants in the United States, exceeding their representation in the general population. The battle against organ rejection is a daily struggle, with half of all kidney transplants failing within ten years. The issue is further compounded by the severe organ shortage, disproportionately affecting these communities. Approximately 50% of individuals on the transplant waiting list are Black or Hispanic/Latino, highlighting the urgent need for equitable post-transplant care and access to transplantation.
Broad Support and National Attention:
The coalition led by Al B! and Rev. Sharpton has garnered widespread support from transplant patients and the medical community. Leading national professional transplant medical associations, including the American Society of Transplant Surgeons and the American Society of Transplantation, have expressed opposition to the Medicare coverage restrictions. Additionally, a bipartisan group of representatives in Congress, along with grassroots transplant patient group “Honor the Gift coalition,” have raised concerns and demanded answers from CMS regarding the rollbacks.
Al B! and Rev. Sharpton express hope that the House Congressional Black Caucus and other influential bodies will join their efforts to restore Medicare coverage for these vital blood tests. To amplify their cause, hundreds of transplant recipients will gather in Washington, D.C., from December 4-6 for a series of activities, including meetings with congressional leaders and a press conference. The ultimate goal is to ensure that all transplant recipients, regardless of their background or socioeconomic status, have access to the necessary tools and care for a healthier future.
The formation of the “Health Equity in Transplantation Coalition” led by Al B. Sure! and Rev. Al Sharpton marks a significant step toward addressing the disparities faced by minority and underserved communities in transplant care. By opposing the Medicare cutbacks for transplant patient blood tests, this coalition strives to ensure that all transplant recipients have access to early detection of organ rejection, regardless of their background. Through their collective efforts, they aim to build a more equitable and inclusive healthcare system for all.
Nutrient found in beef and dairy improves immune response to cancer
Newswise — Trans-vaccenic acid (TVA), a long-chain fatty acid found in meat and dairy products from grazing animals such as cows and sheep, improves the ability of CD8+ T cells to infiltrate tumors and kill cancer cells, according to a new study by researchers from the University of Chicago.
The research, published this week in Nature, also shows that patients with higher levels of TVA circulating in the blood responded better to immunotherapy, suggesting that it could have potential as a nutritional supplement to complement clinical treatments for cancer.
“There are many studies trying to decipher the link between diet and human health, and it’s very difficult to understand the underlying mechanisms because of the wide variety of foods people eat. But if we focus on just the nutrients and metabolites derived from food, we begin to see how they influence physiology and pathology,” said Jing Chen, PhD, the Janet Davison Rowley Distinguished Service Professor of Medicine at UChicago and one of the senior authors of the new study. “By focusing on nutrients that can activate T cell responses, we found one that actually enhances anti-tumor immunity by activating an important immune pathway.”
Finding nutrients that activate immune cells
Chen’s lab focuses on understanding how metabolites, nutrients and other molecules circulating in the blood influence the development of cancer and response to cancer treatments. For the new study, two postdoctoral fellows, Hao Fan, PhD and Siyuan Xia, PhD, both co-first authors, started with a database of around 700 known metabolites that come from food and assembled a “blood nutrient” compound library consisting of 235 bioactive molecules derived from nutrients. They screened the compounds in this new library for their ability to influence anti-tumor immunity by activating CD8+ T cells, a group of immune cells critical for killing cancerous or virally infected cells.
After the scientists evaluated the top six candidates in both human and mouse cells, they saw that TVA performed the best. TVA is the most abundant trans fatty acid present in human milk, but the body cannot produce it on its own. Only about 20% of TVA is broken down into other byproducts, leaving 80% circulating in the blood. “That means there must be something else it does, so we started working on it more,” Chen said.
The researchers then conducted a series of experiments with cells and mouse models of diverse tumor types. Feeding mice a diet enriched with TVA significantly reduced the tumor growth potential of melanoma and colon cancer cells compared to mice fed a control diet. The TVA diet also enhanced the ability of CD8+ T cells to infiltrate tumors.
The team also performed a series of molecular and genetic analyses to understand how TVA was affecting the T cells. These included a new technique for monitoring transcription of single-stranded DNA called kethoxal-assisted single-stranded DNA sequencing, or KAS-seq, developed by Chuan He, PhD, the John T. Wilson Distinguished Service Professor of Chemistry at UChicago and another senior author of the study. These additional assays, done by both the Chen and He labs, showed that TVA inactivates a receptor on the cell surface called GPR43 which is usually activated by short-chain fatty acids often produced by gut microbiota. TVA overpowers these short-chain fatty acids and activates a cellular signaling process known as the CREB pathway, which is involved in a variety of functions including cellular growth, survival, and differentiation. The team also showed that mouse models where the GPR43 receptor was exclusively removed from CD8+ T cells also lacked their improved tumor fighting ability.
Finally, the team also worked with Justin Kline, MD, Professor of Medicine at UChicago, to analyze blood samples taken from patients undergoing CAR-T cell immunotherapy treatment for lymphoma. They saw that patients with higher levels of TVA tended to respond to treatment better than those with lower levels. They also tested cell lines from leukemia by working with Wendy Stock, MD, the Anjuli Seth Nayak Professor of Medicine, and saw that TVA enhanced the ability of an immunotherapy drug to kill leukemia cells.
Focus on the nutrients, not the food
The study suggests that TVA could be used as a dietary supplement to help various T cell-based cancer treatments, although Chen points out that it is important to determine the optimized amount of the nutrient itself, not the food source. There is a growing body of evidence about the detrimental health effects of consuming too much red meat and dairy, so this study shouldn’t be taken as an excuse to eat more cheeseburgers and pizza; rather, it indicates that nutrient supplements such as TVA could be used to promote T cell activity. Chen thinks there may be other nutrients that can do the same.
“There is early data showing that other fatty acids from plants signal through a similar receptor, so we believe there is a high possibility that nutrients from plants can do the same thing by activating the CREB pathway as well,” he said.
The new research also highlights the promise of this “metabolomic” approach to understanding how the building blocks of diet affect our health. Chen said his team hopes to build a comprehensive library of nutrients circulating in the blood to understand their impact on immunity and other biological processes like aging.
“After millions of years of evolution, there are only a couple hundred metabolites derived from food that end up circulating in the blood, so that means they could have some importance in our biology,” Chen said. “To see that a single nutrient like TVA has a very targeted mechanism on a targeted immune cell type, with a very profound physiological response at the whole organism level—I find that really amazing and intriguing.”
The study, “Trans-vaccenic acid reprograms CD8+ T cells and anti-tumor immunity,” was supported by the National Institutes of Health (grants CA140515, CA174786, CA276568, 1375 HG006827, K99ES034084), a UChicago Biological Sciences Division Pilot Project Award, the Ludwig Center at UChicago, the Sigal Fellowship in Immuno-oncology, the Margaret E. Early Medical Research Trust, the AASLD Foundation a Harborview Foundation Gift Fund, and the Howard Hughes Medical Institute.
Community9 months ago
Diana Gregory Talks to us about Diana Gregory’s Outreach Services
Senior Pickleball Report10 months ago
ACE PICKLEBALL CLUB TO DEBUT THEIR HIGHLY ANTICIPATED INDOOR PICKLEBALL FRANCHISES IN THE US, IN EARLY 2023
Entertainment12 months ago
The Absolute Most Comfortable Pickleball Shoe I’ve Ever Worn!
Blog10 months ago
Unique Experiences at the CitizenM
Automotive9 months ago
2023 Nissan Sentra pricing starts at $19,950
Senior Pickleball Report10 months ago
“THE PEOPLE’S CHOICE AWARDS OF PICKLEBALL” – VOTING OPEN
influencers9 months ago
Keeping Pickleball WEIRD, INEXPENSIVE and FUN? These GUYS are!
Blog11 months ago
Assistory Showing Support on Senior Assist Day